These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9858870)
1. Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum. Underwood PA; Mitchell SM; Whitelock JM J Vasc Res; 1998; 35(6):449-60. PubMed ID: 9858870 [TBL] [Abstract][Full Text] [Related]
2. Low density lipoproteins in human plasma make vascular smooth muscle cells resistant to growth inhibition by heparin. Underwood PA; Mitchell SM Cardiovasc Res; 2000 Sep; 47(4):749-58. PubMed ID: 10974223 [TBL] [Abstract][Full Text] [Related]
3. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells. Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445 [TBL] [Abstract][Full Text] [Related]
4. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation. Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1 and ascorbate regulate proliferation of cultured smooth muscle cells by independent mechanisms. Ivanov VO; Rabovsky AB; Ivanova SV; Niedzwiecki A Atherosclerosis; 1998 Sep; 140(1):25-34. PubMed ID: 9733212 [TBL] [Abstract][Full Text] [Related]
6. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum. Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434 [TBL] [Abstract][Full Text] [Related]
7. The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cells. Peterson TE; Kleppe LS; Caplice NM; Pan S; Mueske CS; Simari RD Biochem Biophys Res Commun; 1999 Nov; 265(3):722-7. PubMed ID: 10600487 [TBL] [Abstract][Full Text] [Related]
8. Human arterial smooth muscle cells in culture. Effects of platelet-derived growth factor and heparin on growth in vitro. Fager G; Hansson GK; Ottosson P; Dahllöf B; Bondjers G Exp Cell Res; 1988 Jun; 176(2):319-35. PubMed ID: 2837401 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist. Segev A; Aviezer D; Safran M; Gross Z; Yayon A Cardiovasc Res; 2002 Jan; 53(1):232-41. PubMed ID: 11744033 [TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis. Patel MK; Refson JS; Schachter M; Hughes AD Br J Pharmacol; 1999 May; 127(2):361-8. PubMed ID: 10385234 [TBL] [Abstract][Full Text] [Related]
12. Heparin inhibits proliferation of fetal vascular smooth muscle cells in the absence of platelet-derived growth factor. Benitz WE; Lessler DS; Coulson JD; Bernfield M J Cell Physiol; 1986 Apr; 127(1):1-7. PubMed ID: 2420809 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. Weber H; Taylor DS; Molloy CJ J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348 [TBL] [Abstract][Full Text] [Related]
14. Decreased susceptibility of cultured smooth muscle cells from SHR rats to growth inhibition by heparin. Resink TJ; Scott-Burden T; Baur U; Bürgin M; Bühler FR J Cell Physiol; 1989 Jan; 138(1):137-44. PubMed ID: 2910881 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927 [TBL] [Abstract][Full Text] [Related]
16. COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells. Delmolino LM; Stearns NA; Castellot JJ J Cell Physiol; 2001 Jul; 188(1):45-55. PubMed ID: 11382921 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus. Sarjeant JM; Lawrie A; Kinnear C; Yablonsky S; Leung W; Massaeli H; Prichett W; Veinot JP; Rassart E; Rabinovitch M Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2172-7. PubMed ID: 14551159 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells. Sivamurthy N; Stone DH; Logerfo FW; Quist WC J Vasc Surg; 2001 Oct; 34(4):716-23. PubMed ID: 11668329 [TBL] [Abstract][Full Text] [Related]